There is clinical potential for miRNA as therapeutics for cardiovascular disease

Many miRNAs have been reported to be altered in cardiovascular disease; both cellular and extracellular levels.  Understanding exactly when and how miRNA expression is influencing the development of normal cells into diseased cells will undoubtedly help lead to improved diagnosis and possibly treatment for cardiovascular diseases.

Expression profiling results have shown that miRNAs are involved in cardiac hypertrophy formation and thus might be a new therapeutic target for cardiovascular diseases involving cardiac hypertrophy such as hypertension, ischemic heart disease, valvular diseases, and endocrine disorders.

Indeed, researchers have demonstrated that inhibition of specific miRNAs can spare cardiomyocytes from death during myocardial infarction.

Read more about how LC Sciences is helping clinicians and researchers to:

LC Sciences offers a range of services applicable to clinical cardiovascular research.
Contact us to find out more.

microRNA Sequencing Service

microRNA sequencing is a new method and a powerful tool to identify and quantitatively decode the entire population of microRNAs in your sample. LC Sciences now provides a comprehensive microRNA sequencing service…

microRNA Microarray Services

A genome-wide microRNA (miRNA) expression profiling service using µParaflo® technology and proprietary probe design, which enable highly sensitive and specific direct…